HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.

Abstract
We have previously shown that melatonin reduces postischemic rises in the blood-brain barrier (BBB) permeability and improves neurovascular dysfunction and hemorrhagic transformation following ischemic stroke. It is known that activation of the matrix metalloproteinases (MMPs) plays a crucial role in the pathogenesis of brain edema and hemorrhagic transformation after ischemic stroke. We, herein, investigated whether melatonin would ameliorate MMP-2 and MMP-9 activation and expression in a rat model of transient focal cerebral ischemia. Adult male Sprague-Dawley rats were subjected to a 90-min middle cerebral artery (MCA) occlusion using an intraluminal filament. Melatonin (5 mg/kg) or vehicle was intravenously injected upon reperfusion. Brain infarction and hemorrhage within infarcts were measured, and neurological deficits were scored. The activity and expression of MMP-2 and MMP-9 were determined by zymography, in situ zymography and Western immunoblot analysis. Cerebral ischemia-reperfusion induced increased pro-MMP-9 and MMP-9 activity and expression 24 hr after reperfusion onset. Relative to controls, melatonin-treated animals, however, had significantly reduced levels in the MMP-9 activity and expression (P < 0.01), in addition to reduced brain infarct volume and hemorrhagic transformation as well as improved sensorimotor neurobehavioral outcomes. No significant change in MMP-2 activity was observed throughout the course experiments. Our results indicate that the melatonin-mediated reductions in ischemic brain damage and reperfusion-induced hemorrhage are partly attributed to its ability to reduce postischemic MMP-9 activation and increased expression, and further support the fact that melatonin is a suitable as an add-on to thrombolytic therapy for ischemic stroke patients.
AuthorsYu-Chang Hung, Tsung-Ying Chen, E-Jian Lee, Wan-Ling Chen, Sheng-Yang Huang, Wei-Ting Lee, Ming-Yang Lee, Hung-Yi Chen, Tian-Shung Wu
JournalJournal of pineal research (J Pineal Res) Vol. 45 Issue 4 Pg. 459-67 (Nov 2008) ISSN: 1600-079X [Electronic] England
PMID18624955 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Melatonin
Topics
  • Animals
  • Blotting, Western
  • Brain (enzymology, pathology)
  • Brain Infarction (drug therapy, pathology)
  • Cerebral Hemorrhage (drug therapy, enzymology)
  • Enzyme Activation (drug effects)
  • Gene Expression Regulation
  • Ischemic Attack, Transient (drug therapy, enzymology, physiopathology)
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Melatonin (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy, enzymology, physiopathology)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: